Detalhe da pesquisa
1.
Response to: Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications, by Jerome Boursier et al.
Clin Gastroenterol Hepatol
; 21(2): 559-560, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398570
2.
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
J Hepatol
; 60(4): 706-14, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24291240
3.
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).
J Hepatol
; 61(5): 994-1003, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25016224
4.
Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.
J Hepatol
; 59(4): 675-83, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23712051
5.
Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysis.
Aliment Pharmacol Ther
; 58(9): 888-902, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37642160
6.
Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia.
Hepatol Commun
; 7(10)2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738404
7.
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.
J Hepatol
; 57(3): 541-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22612998
8.
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19.
Biomedicines
; 10(3)2022 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35327501
9.
Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection.
Gastro Hep Adv
; 1(3): 393-402, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35174366
10.
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age.
BMC Gastroenterol
; 11: 39, 2011 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21492460
11.
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.
JHEP Rep
; 3(4): 100298, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34142073
12.
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes.
Aliment Pharmacol Ther
; 54(7): 952-966, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34398492
13.
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes.
Eur J Gastroenterol Hepatol
; 32(8): 998-1007, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31789950
14.
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19.
PLoS One
; 15(11): e0242306, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216772
15.
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis.
Eur J Gastroenterol Hepatol
; 31(3): 393-402, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516570
16.
LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.
Aliment Pharmacol Ther
; 49(3): 308-320, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30569507
17.
Impact of steatosis and inflammation definitions on the performance of NASH tests.
Eur J Gastroenterol Hepatol
; 30(4): 384-391, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29280921
18.
Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference.
Eur J Gastroenterol Hepatol
; 30(5): 569-577, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29406435
19.
Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.
Aliment Pharmacol Ther
; 48(10): 1117-1127, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334263
20.
Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison.
PLoS One
; 11(10): e0163276, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27706177